TEVJF Financials 07/19/2014 18:54:25
Teva Pharmaceutical Industries Ltd.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 20,314,000 20,317,000 18,312,000 16,121,000
Cost of Revenue 9,607,000 9,665,000 8,797,000 7,056,000
Gross Profit 10,707,000 10,652,000 9,515,000 9,065,000
Operating Expenses
Research and Development 1,427,000 1,356,000 1,095,000 951,000
Sales, General and Admin. 5,319,000 5,117,000 4,410,000 3,833,000
Non-Recurring Items 2,312,000 1,974,000 901,000 410,000
Other - - - -
Operating Income 1,649,000 2,205,000 3,109,000 3,871,000
Income From Continuing Operations
Add'l Income/Expense Items - - - -
Earnings Before Interest and Tax 1,649,000 2,205,000 3,109,000 3,871,000
Interest Expense 399,000 386,000 153,000 225,000
Earnings Before Tax 1,250,000 1,819,000 2,956,000 3,646,000
Income Tax (43,000) (137,000) 127,000 283,000
Minority Interest (16,000) (53,000) 9,000 8,000
Equity Earnings Unconsolidated Subsidiary (40,000) (46,000) (61,000) (24,000)
Net Income Cont. Operations 1,269,000 1,963,000 2,759,000 3,331,000
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 1,269,000 1,963,000 2,759,000 3,331,000
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 1,269,000 1,963,000 2,759,000 3,331,000
Teva Pharmaceutical Industries Ltd.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 20,314,000 20,317,000 18,312,000 16,121,000
Cost of Revenue 9,607,000 9,665,000 8,797,000 7,056,000
Gross Profit 10,707,000 10,652,000 9,515,000 9,065,000
Operating Expenses
Research and Development 1,427,000 1,356,000 1,095,000 951,000
Sales, General and Admin. 5,319,000 5,117,000 4,410,000 3,833,000
Non-Recurring Items 2,312,000 1,974,000 901,000 410,000
Other - - - -
Operating Income 1,649,000 2,205,000 3,109,000 3,871,000
Income From Continuing Operations
Add'l Income/Expense Items - - - -
Earnings Before Interest and Tax 1,649,000 2,205,000 3,109,000 3,871,000
Interest Expense 399,000 386,000 153,000 225,000
Earnings Before Tax 1,250,000 1,819,000 2,956,000 3,646,000
Income Tax (43,000) (137,000) 127,000 283,000
Minority Interest (16,000) (53,000) 9,000 8,000
Equity Earnings Unconsolidated Subsidiary (40,000) (46,000) (61,000) (24,000)
Net Income Cont. Operations 1,269,000 1,963,000 2,759,000 3,331,000
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 1,269,000 1,963,000 2,759,000 3,331,000
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 1,269,000 1,963,000 2,759,000 3,331,000
